FDA Adverse Event Malfunction Summary report: N

MATNEU SCR Ø1.5 SELF-DRILL L4 TAN 4U I/C

MDR report key: 2926039 · Received January 23, 2013

Report

Report Number
8030965-2013-00217
Event Type
Malfunction
Date Received
January 23, 2013
Date of Event
November 30, 2012
Report Date
December 28, 2012
Manufacturer
SYNTHES GMBH
Product Code
JEY
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE USED FOR TREATMENT AND NOT DIAGNOSIS. THE MANUFACTURING RECORDS WERE REVIEWED AND NO COMPLAINT RELATED ISSUES WERE FOUND. WE HAVE SENT THE COMPLAINED SCREW TO OUR MATERIAL SCIENCE AND TESTING DEPARTMENT FOR INVESTIGATION. THE MATERIAL MET SPECIFICATIONS. AN EXAMINATION VIA SEM WAS COMPLETED: THE PRESENT SCREW BROKE ACCORDING TO A DUCTILE FORCED FRACTURE DURING INSERTION BY APPLYING A HIGH TORSIONAL LOAD. A REASON FOR AN INTRA-OPERATIVE FAILURE FOR THE MATRIX NEURO SCREW COULD BE INSERTION OF THE SCREW IN AN EXCEPTIONAL HARD BONE WITHOUT PRE-DRILLING. THE PERFORMED INVESTIGATION COULD NOT DETECT ANY MATERIAL FAULTS.

Additional Manufacturer Narrative · 1

DEVICE USED FOR TREATMENT AND NOT DIAGNOSIS. DEVICE IS NOT DISTRIBUTED IN THE UNITED STATES, BUT IS SIMILAR TO DEVICE MARKETED IN THE USA. THE DEVICE WAS RECEIVED, THE INVESTIGATION COULD NOT BE COMPLETED, AND NO CONCLUSION COULD BE DRAWN, AS PRODUCT IS ENTERING THE COMPLAINT SYSTEM.

Description of Event or Problem · 1

THIS IS 1 OF 2 REPORTS FOR COMPLAINT (B)(4).

Description of Event or Problem · 1

A DEVICE REPORT FROM (B)(4) INDICATED A HOSPITAL IN (B)(6) REPORTED: DURING A PROCEDURE FOR A PATIENT WITH A BRAIN TUMOR: TWO SCREWS BROKE UPON INSERTION. ONE SCREW, THE TIP WAS BROKEN, THE SECOND SCREW THE SCREW HEAD WAS CHIPPED OFF. NO FURTHER INFORMATION IS AVAILABLE. THIS IS 1 OF 2 REPORTS FOR THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
32467 MATNEU SCR Ø1.5 SELF-DRILL L4 TAN 4U I/C MATNEU SCREW JEY SYNTHES GMBH 2761242

Patients

Seq Age Sex Outcome Treatment
1 72 YR